MANCIA, GIUSEPPE
MANCIA, GIUSEPPE
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Adherence to perindopril/amlodipine/atorvastatin combination according to the administration strategy
2025 Morabito, G; Rea, F; Corrao, G; Mancia, G
Clarifying the definition of ‘elevated’ blood pressure in the 2024 European Society of Cardiology hypertension guidelines
2025 Mancia, G; Grassi, G; Kjeldsen, S
Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials
2025 Manolis, A; Karakasis, P; Patoulias, D; Doumas, M; Kallistratos, M; Thomopoulos, C; Koutsaki, M; Grassi, G; Mancia, G
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY
2025 Massabò, D; Quarti-Trevano, F; Seravalle, G; Facchetti, R; Dell'Oro, R; Tsioufis, K; Dimitriadis, K; Manta, E; Mancia, G; Grassi, G
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity
2025 Quarti-Trevano, F; Seravalle, G; Facchetti, R; Tsioufis, K; Dimitriadis, K; Manta, E; Mancia, G; Grassi, G
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population
2025 Quarti-Trevano, F; Facchetti, R; Cuspidi, C; Mancia, G; Grassi, G
Increased arterial stiffness and left ventricular remodelling as markers of masked hypertension: findings from the PAMELA population
2025 Cuspidi, C; Facchetti, R; Gherbesi, E; Quarti-Trevano, F; Vanoli, J; Mancia, G; Grassi, G
New onset left atrial dilatation in the general population: A quarter-century follow-up
2025 Cuspidi, C; Facchetti, R; Quarti-Trevano, F; Dell'Oro, R; Faggiano, A; Mancia, G; Grassi, G
Nocturnal blood pressure: pathophysiology, measurement and clinical implications. Position paper of the European Society of Hypertension
2025 Parati, G; Pengo, M; Avolio, A; Azizi, M; Bothe, T; Burnier, M; Cappuccio, F; Sierra, A; Fava, C; Gironacci, M; Hoshide, S; Kario, K; Kollias, A; Lombardi, C; Maiolino, G; Maule, S; Narkiewicz, K; Ohkubo, T; Palatini, P; Pepin, J; Sarafidis, P; Schutte, A; Silvani, A; Stergiou, G; Verdecchia, P; Mancia, G; Bilo, G
Obituary Allyn L. Mark: a reflection by European, Canadian and Australian friends
2025 Grassi, G; Floras, J; Narkiewicz, K; Esler, M; Mancia, G
Office and out-of-office blood pressure in the European guidelines on hypertension: A clinical perspective
2025 Grassi, G; Ambrosino, P; Mancia, G
On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE Trial
2025 Olsen, E; Mariampillai, J; Schmieder, R; Jamerson, K; Søraas, C; Mancia, G; Mehlum, M; Liestøl, K; Larstorp, A; Halvorsen, L; Waldum-Grevbo, B; Mo, R; Kjeldsen, S; Weber, M
Reproducibility and Treatment Effect on Office and Ambulatory Pressure Relation
2025 Mancia, G; Facchetti, R; Quarti-Trevano, F; Grassi, G
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies
2025 Grassi, G; Quarti Trevano, F; Cuspidi, C; Sanidas, E; Mancia, G; Thomopoulos, C
The Autonomic Nervous System and Inflammation in Chronic Kidney Disease
2025 Zoccali, C; Mallamaci, F; Kanbay, M; Tuttle, K; Kotanko, P; De Caterina, R; Grassi, G; Mancia, G
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)
2025 Ostrowska, A; Wojciechowska, W; Rajzer, M; Weber, T; Bursztyn, M; Persu, A; Stergiou, G; Kiełbasa, G; Chrostowska, M; Doumas, M; Parati, G; Bilo, G; Grassi, G; Mancia, G; Januszewicz, A; Kreutz, R; Narkiewicz, K; Dubiela, A; Imprialos, K; Stavropoulos, K; de Freminville, J; Azizi, M; Cunha, P; Lewandowski, J; Strzelczyk, J; Wuerzner, G; Gosk-Przybyłek, M; Szwęch, E; Prejbisz, A; Van der Niepen, P; Kahan, T; Jekell, A; Spaak, J; Tsioufis, K; Ehret, G; Doroszko, A; Kubalski, P; Polonia, J; Styczkiewicz, K; Styczkiewicz, M; Mazur, S; Veglio, F; Rabbia, F; Eula, E; Águila, F; Sarzani, R; Spannella, F; Jarai, Z; Papadopoulos, D; Sublet, M; Grassos, C; Kahrimanidis, I; Gkaliagkousi, E; Triantafyllou, A; Grodzicki, T; Wizner, B; Seweryn, A; Moczulska, B; Ntineri, A; Robles, N; Widmiski, J; Zbroch, E
When should antihypertensive drug treatment be started? Discrepancies between the 2023 European Society of Hypertension and the 2024 European Society of Cardiology guidelines
2025 Mancia, G; Grassi, G; Kjeldsen, S
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) (vol 41, pg 1874, 2023)
2024 Mancia, G; Kreutz, R; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension
2024 Kreutz, R; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Muiesan, M; Tsioufis, K; de Pinho, R; Albini, F; Boivin, J; Doumas, M; Nemcsik, J; Rodilla, E; Agabiti-Rosei, E; Algharably, E; Agnelli, G; Benetos, A; Hitij, J; Cífková, R; Cornelissen, V; Danser, A; Delles, C; Huelgas, R; Járai, Z; Palatini, P; Pathak, A; Persu, A; Polonia, J; Sarafidis, P; Stergiou, G; Thomopoulos, C; Wanner, C; Weber, T; Williams, B; Kjeldsen, S; Mancia, G
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension
2024 Sarafidis, P; Schmieder, R; Burnier, M; Persu, A; Januszewicz, A; Halimi, J; Arici, M; Ortiz, A; Wanner, C; Mancia, G; Kreutz, R